Health Trials

Facet Joint Pain

3

Review clinical trials related to Facet Joint Pain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks

This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a lumbar medial branch block (MBB).

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of PittsburghUpdated: Jun 4, 2026Locations: 1
Eligibility criteria

Scheduled for lumbar MBB in UPMC Pain Management clinics [+5]

History of spine surgery at the level of the lumbar MBB [+4]

Read more
Status: Not yet recruiting

ITX24-01 in Adult Male and Female Patients With Select Types of Severe Chronic Neck- and Lower Back Pain

The study is a single ascending dose (SAD), single-center, randomised, double-blind, placebo-controlled Phase 1b clinical trial designed to evaluate the safety, tolerability, and preliminary analgesic efficacy of ITX24-01 in patients with severe chronic zygapophysial joint pain (facet joint pain). The study consists of three dose escalation cohorts and one extension cohort.

Participants needed: 32
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Interventional AnalgesiX Inc.Updated: Apr 9, 2026Locations: 1
Eligibility criteria

Male or female. Women of childbearing potential must be willing to use contracep... [+7]

Pregnant or breastfeeding [+9]

Read more
Status: Recruiting

Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain

The purpose of this study is to see if the use of Alocyte (cord blood plasma plus mononucleic cells) will be safe, well tolerated, and whether it causes any side effects. The study will also examine if the use of the Investigational Product (IP) is able to reduce local inflammation or alleviate Facetogenic back pain

Participants needed: 15
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Alimorad FarshchianUpdated: Jan 13, 2026Locations: 1
Eligibility criteria

Subjects age > 18 years at the time of signing the Informed Consent Form. [+8]

Previous surgical intervention for back pain [+29]

Read more